Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in Adults | Zendy

Jonathan Sive | Zendy; Kirsty Thomson | Zendy; Emma Morris | Zendy; Katherine N. Ward | Zendy; Karl S. Peggs | Zendy

Open Access

Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in Adults

Author(s) -

Jonathan Sive,

Kirsty Thomson,

Emma Morris,

Katherine N. Ward,

Karl S. Peggs

Publication year - 2012

Publication title -

clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis689

Subject(s) - medicine , alemtuzumab , transplantation , stem cell , immunology , oncology , genetics , biology

Adenovirus infection is a potentially serious complication of allogeneic hematopoietic stem cell transplantation (HSCT) and has been reported to occur more frequently following T-cell-depleted reduced-intensity HSCT. However, the true incidence and clinical significance as well as the relationship of disease to viremic titer remain unclear due to wide variation in study populations and methodology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research